The MicroRNA-130/301 Family Controls Vasoconstriction in Pulmonary Hypertension
Wolfgang Kuebler
Journal of Biological Chemistry, 2014
View PDFchevron_right
Discordant regulation of microRNA between multiple experimental models and human pulmonary hypertension
Mohamad Taha
Chest, 2015
View PDFchevron_right
MicroRNAs in Pulmonary Hypertension, from Pathogenesis to Diagnosis and Treatment
Qinyi Xia
Biomolecules
View PDFchevron_right
MicroRNA-21 Integrates Pathogenic Signaling to Control Pulmonary Hypertension: Results of a Network Bioinformatics Approach
S. Rabello
Circulation, 2012
View PDFchevron_right
miR-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension
Lin Deng, Margaret Maclean
Circulation research, 2015
View PDFchevron_right
A Role for miR-145 in Pulmonary Arterial Hypertension: Evidence From Mouse Models and Patient Samples
John Mcclure
Circulation Research, 2012
View PDFchevron_right
Identification of miR-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 and PKM2
Mohamad Taha
Circulation, 2017
View PDFchevron_right
An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension
Janet Lighthouse
View PDFchevron_right
Distinct plasma gradients of microRNA‐204 in the pulmonary circulation of patients suffering from WHO Groups I and II pulmonary hypertension
Akaya Smith
Pulmonary Circulation, 2019
View PDFchevron_right
MicroRNAs-control of essential genes: Implications for pulmonary vascular disease
Brian Comer, William Gerthoffer
Pulmonary Circulation, 2011
View PDFchevron_right
MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension
James Iremonger
The Journal of clinical investigation, 2016
View PDFchevron_right
Assessment of microRNA and gene dysregulation in pulmonary hypertension by endoarterial biopsy
Humberto Restrepo
Pulmonary circulation
View PDFchevron_right
Deacetylation of MicroRNA-124 in Fibroblasts: Role in Pulmonary Hypertension
Nicole Pohl
Circulation Research, 2014
View PDFchevron_right
MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways
Yuanjia Tang
Experimental & molecular medicine, 2018
View PDFchevron_right
Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension
Soma Jyothula
Respiratory Research, 2022
View PDFchevron_right
Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2
YIN XUAN TAO
Scientific reports, 2016
View PDFchevron_right
Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline
Raya Khanin
Arteriosclerosis, Thrombosis, and Vascular Biology, 2010
View PDFchevron_right
Hypoxia Mediates Mutual Repression between microRNA-27a and PPARγ in the Pulmonary Vasculature
Bum-Yong Kang
PLoS ONE, 2013
View PDFchevron_right
MicroRNA-124 Controls the Proliferative, Migratory, and Inflammatory Phenotype of Pulmonary Vascular Fibroblasts
Soni Pullamsetti
Circulation Research, 2013
View PDFchevron_right
Inhibition of MicroRNA-17 Improves Lung and Heart Function in Experimental Pulmonary Hypertension
Soni Pullamsetti
American Journal of Respiratory and Critical Care Medicine, 2012
View PDFchevron_right
MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling
Isabel Blanco
American Journal of Respiratory Cell and Molecular Biology, 2018
View PDFchevron_right
Characterization of vascular remodeling associated with pulmonary hypertension in miR-200b knockout mice
Samira Seif
2019
View PDFchevron_right
From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension
Roxane Paulin
Journal of Molecular Medicine-jmm
View PDFchevron_right
Upregulation of miR-335-3p by NF-κB Transcriptional Regulation Contributes to the Induction of Pulmonary Arterial Hypertension via APJ during Hypoxia
Fangzhou Ye
International Journal of Biological Sciences
View PDFchevron_right
microRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1
LI Shanshan
View PDFchevron_right
Krüppel-like factor 2- induced microRNAs: implications for treatment of pulmonary hypertension
Hebah Sindi
2019
View PDFchevron_right
miR-138 and miR-25 Downregulate MCU, Causing Pulmonary Arterial Hypertension's Cancer Phenotype
Danchen Wu
American journal of respiratory and critical care medicine, 2016
View PDFchevron_right
Long Range Endocrine Delivery of Circulating miR-210 to Endothelium Promotes Pulmonary Hypertension
Jimin Yang
Circulation Research, 2020
View PDFchevron_right
Downregulation of miR-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension
Ryan Wong
Circulation, 2015
View PDFchevron_right
Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension
Sabrina Setembre Batah
Frontiers in Pharmacology, 2021
View PDFchevron_right
MicroRNAs (miRNAs) Role in Hypertension: Pathogenesis and Promising Therapeutics
Ahmed Shaheen
View PDFchevron_right
Peer Review #2 of "miRDRN—miRNA disease regulatory network: a tool for exploring disease and tissue-specific microRNA regulatory networks (v0.1)
Dr. Mohamed Rady
2019
View PDFchevron_right
MicroRNA-1 Is Decreased by Hypoxia and Contributes to the Development of Pulmonary Vascular Remodeling via Regulation of Sphingosine Kinase 1
Roberto Machado
American journal of physiology. Lung cellular and molecular physiology, 2017
View PDFchevron_right